BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 31638600)

  • 1. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
    Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
    J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
    Cresswell GM; Wang B; Kischuk EM; Broman MM; Alfar RA; Vickman RE; Dimitrov DS; Kularatne SA; Sundaram CP; Singhal S; Eruslanov EB; Crist SA; Elzey BD; Ratliff TL; Low PS
    Cancer Res; 2021 Feb; 81(3):671-684. PubMed ID: 33203700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.
    Leonard F; Curtis LT; Hamed AR; Zhang C; Chau E; Sieving D; Godin B; Frieboes HB
    Cancer Immunol Immunother; 2020 May; 69(5):731-744. PubMed ID: 32036448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100P facilitates LUAD progression via PKA/c-Jun-mediated tumor-associated macrophage recruitment and polarization.
    Gao L; Bai Y; Zhou J; Liang C; Dong Y; Han T; Liu Y; Guo J; Wu J; Hu D
    Cell Signal; 2024 Aug; 120():111179. PubMed ID: 38640980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8
    Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX
    J Hepatol; 2024 May; ():. PubMed ID: 38759889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pumilio RNA binding family member 1 deficiency activates anti-tumor immunity in hepatocellular carcinoma via restraining M2 macrophage polarization.
    Yu Y; Nie G; Ren YW; Ouyang L; Ni CM
    Cell Cycle; 2024 May; ():1-11. PubMed ID: 38794797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.
    Liu M; Tong Z; Ding C; Luo F; Wu S; Wu C; Albeituni S; He L; Hu X; Tieri D; Rouchka EC; Hamada M; Takahashi S; Gibb AA; Kloecker G; Zhang HG; Bousamra M; Hill BG; Zhang X; Yan J
    J Clin Invest; 2020 Apr; 130(4):2081-2096. PubMed ID: 31945018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling.
    Cai Z; Li W; Hager S; Wilson JL; Afjehi-Sadat L; Heiss EH; Weichhart T; Heffeter P; Weckwerth W
    Cell Mol Immunol; 2024 May; 21(5):448-465. PubMed ID: 38409249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lapachol inhibits the growth of lung cancer by reversing M2-like macrophage polarization via activating NF-κB signaling pathway.
    Zhang Z; Bai L; Lu C; Li X; Wu Y; Zhang X; Shen Y
    Cell Signal; 2023 Dec; 112():110902. PubMed ID: 37751828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression.
    Li Y; Chen Y; Zhao C; Yang Y; Zhang M; Cheng H; Li Q; Wang M
    Phytomedicine; 2024 Jun; 128():155532. PubMed ID: 38493722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major vault protein regulates tumor-associated macrophage polarization through interaction with signal transducer and activator of transcription 6.
    Yu C; Zhu Q; Ma C; Luo C; Nie L; Cai H; Wang Q; Wang F; Ren H; Yan H; Xu K; Zhou L; Zhang C; Lu G; Lu Z; Zhu Y; Liu S
    Front Immunol; 2023; 14():1289795. PubMed ID: 38264642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8
    Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J
    Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer.
    Racioppi L; Nelson ER; Huang W; Mukherjee D; Lawrence SA; Lento W; Masci AM; Jiao Y; Park S; York B; Liu Y; Baek AE; Drewry DH; Zuercher WJ; Bertani FR; Businaro L; Geradts J; Hall A; Means AR; Chao N; Chang CY; McDonnell DP
    Nat Commun; 2019 Jun; 10(1):2450. PubMed ID: 31164648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAMPT-Driven M2 Polarization of Tumor-Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer.
    Hong SM; Lee AY; Kim BJ; Lee JE; Seon SY; Ha YJ; Ng JT; Yoon G; Lim SB; Morgan MJ; Cha JH; Lee D; Kim YS
    Adv Sci (Weinh); 2024 Apr; 11(14):e2303177. PubMed ID: 38308188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An NFAT1-C3a-C3aR Positive Feedback Loop in Tumor-Associated Macrophages Promotes a Glioma Stem Cell Malignant Phenotype.
    Zhang Y; Song Y; Wang X; Shi M; Lin Y; Tao D; Han S
    Cancer Immunol Res; 2024 Mar; 12(3):363-376. PubMed ID: 38289255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.
    Curtis LT; Sebens S; Frieboes HB
    Cancer Immunol Immunother; 2021 May; 70(5):1475-1488. PubMed ID: 33180183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune-metabolic crosstalk between CD3
    Yang Y; Sun L; Chen Z; Liu W; Xu Q; Liu F; Ma M; Chen Y; Lu Y; Fang H; Chen G; Shi Y; Wu D
    Front Immunol; 2023; 14():1033497. PubMed ID: 36845133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages.
    Wei X; Nie S; Liu H; Sun J; Liu J; Li J; Li S; Wang S; Han S; Wang J; Sun Y
    Am J Cancer Res; 2017; 7(11):2220-2233. PubMed ID: 29218246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor-associated macrophage phenotype.
    Boibessot C; Molina O; Lachance G; Tav C; Champagne A; Neveu B; Pelletier JF; Pouliot F; Fradet V; Bilodeau S; Fradet Y; Bergeron A; Toren P
    Clin Transl Med; 2022 Jan; 12(1):e581. PubMed ID: 35075795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP14 Contributes to the Development of the Tumor-Associated Macrophage Phenotype.
    Sturniolo I; Váróczy C; Regdon Z; Mázló A; Muzsai S; Bácsi A; Intili G; Hegedűs C; Boothby MR; Holechek J; Ferraris D; Schüler H; Virág L
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.